Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters

• Konstantin Schlick,

  Roles Conceptualization, Data curation, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University, Salzburg, Austria

  http://orcid.org/0000-0003-4407-7504

  ⨯
• Teresa Magnes,

  Roles Formal analysis, Writing – review & editing

  Affiliation IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University, Salzburg, Austria

  ⨯
• Lukas Ratzinger,

  Roles Conceptualization, Formal analysis, Writing – review & editing

  Affiliation IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University, Salzburg, Austria

  ⨯
• Bernhard Jaud,

  Roles Data curation

  Affiliation IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University, Salzburg, Austria

  ⨯
• Lukas Weiss,

  Roles Methodology, Writing – review & editing

  Affiliation IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University, Salzburg, Austria

  ⨯
• Thomas Melchardt,

  Roles Conceptualization, Methodology, Visualization, Writing – original draft

  Affiliation IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University, Salzburg, Austria

  ⨯
• Richard Greil ,

  Roles Writing – review & editing

  * E-mail: R.Greil@salk.at

  Affiliations IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University, Salzburg, Austria, Salzburg Cancer Research Institute, Salzburg, Austria, Cancer Cluster Salzburg, Salzburg, Austria

  ⨯
• Alexander Egle

  Roles Writing – review & editing

  Affiliations IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University, Salzburg, Austria, Salzburg Cancer Research Institute, Salzburg, Austria, Cancer Cluster Salzburg, Salzburg, Austria

  ⨯